Loading
Health systems earn from treating cancer, not preventing it. Paying them for lower cancer incidence and earlier stage in their population would flip the incentive.
Health systems earn from treating cancer rather than preventing it, so this idea pays capitated insurers and health systems for cancers prevented and caught early, through outcome payments tied to population stage distribution, HPV vaccination coverage and smoking prevalence, adjusted for risk. Fee-for-service rewards volume, whereas outcome-based contracts change practice in other areas of care. The aim is higher screening and vaccination coverage and a stage shift towards stage I-II. The test is a payer pilot of a prevention outcomes bundle in a capitated system such as a Medicare Advantage plan or an NHS integrated care board. Speculative in maturity, it addresses the bottlenecks Prevention we already have is not deployed and Incentives reward me-too drugs and marginal gains.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.